title: [Efficacy and safety of heptral, vitamin B6 and folic acid during toxic hepatitis induced by CCL4].
abstract: The aim of this work was to evaluate of efficacy and safety of complex Heptral, Vitamin B6 and Folic Acid in experimental hepatitis therapy compared with monotherapy. Experiments were carried out on pubertal rats. Eperimental hepatitis models were induced by Tetrachlormethane. The tetrachlormethane intoxication was reproduced by subcutaneous injection of CCL(4) 1ml/kg dissolved in 1ml of olive oil. Cytochrome P450, cytochrome b5, reduced glutation,activity of glutationetranspherase and content of ATP in hepatocytes were measured by the spectrophotometric techniques,but content of homocysteine by chromophtography techniques. Under CCL(4) intoxication disturbance of liver detoxication function, energy deficit and surplus of homocysteine were observed. Treatment of the toxic hepatitis with heptral increased the level of cytochrome P450, cytochrome b5, glutation activity of glutationetranspherase glutathione and reduced content of homocysteine. Complex therapy with Heptral and B6 and folic acid reveal more expressive hepatoprotective effect and safety than monotherapy with Heptral. Complex therapy improves not only the parameters of biotransformation (metabolic and conjugation phase), but also normalizes the level of ATP and homocystein. Vitamins B6 and folic acid increases the efficacy and safety of Heptral. This complex was recomended for treatment of hepatitis.
authors.forename: N A
authors.initials: NA
authors.lastname: Antelava
authors.forename: M I
authors.initials: MI
authors.lastname: Gogoluari
authors.forename: L I
authors.initials: LI
authors.lastname: Gogoluari
authors.forename: N N
authors.initials: NN
authors.lastname: Pirtskhalaĭshvili
authors.forename: M V
authors.initials: MV
authors.lastname: Okudzhava
mesh_terms: D000818:Animals; D002251:Carbon Tetrachloride / Q000633:toxicity; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D015786:Cytochromes b5 / Q000378:metabolism; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D005500:Follow-Up Studies; D022781:Hepatocytes / Q000378:metabolism; D006710:Homocysteine / Q000378:metabolism; D008297:Male; D051381:Rats; D012436:S-Adenosylmethionine / Q000627:therapeutic use*; D016896:Treatment Outcome; D025101:Vitamin B 6 / Q000627:therapeutic use*; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D006710:Homocysteine; D014803:Vitamin B Complex; D012436:S-Adenosylmethionine; D025101:Vitamin B 6; D015786:Cytochromes b5; D003577:Cytochrome P-450 Enzyme System; D005492:Folic Acid; D002251:Carbon Tetrachloride